The CHRNG gene helps build a temporary muscle receptor used before birth, allowing nerves to signal to developing muscles so a baby can move in the womb. If this gene does not work properly, fetal movement may be reduced, which can affect joint position, muscle development, and sometimes breathing at birth. Pathogenic variants in the CHRNG gene are linked to forms of multiple pterygium syndrome, a condition that can include joint stiffness and bands of skin across joints.
What is a gene?
Genes are sections of DNA that provide cells with instructions they can use to make molecules or direct processes in the body. Some genes hold the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they occur, and how strongly they run. As a group, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more in the LearnHub.
Overview
CHRNGGene function
What if the gene works
The CHRNG gene helps build a receptor in developing muscles before birth. This receptor lets nerve signals reach muscle cells, supporting normal movement and joint development in the womb.
Risk
What if the gene does not work
Variants in the CHRNG gene can limit fetal muscle signaling, reducing movement before birth. Milder variants are linked to Escobar syndrome with joint contractures and webbing, while more severe variants may cause a lethal multiple pterygium condition.
Treatment
What does that mean for your treatment
No CHRNG-specific treatment or drug selection approach is currently established for people with a pathogenic or loss-of-function variant in the CHRNG gene. Care is guided by a person’s symptoms and supportive needs rather than by a targeted medicine linked to the CHRNG gene.
Conditions associated with CHRNG
Gene function
What if the gene works
Before birth, muscle movement depends on clear signals passing from nerves to developing muscles. The CHRNG gene helps build a key receiver at the place where a motor nerve meets skeletal muscle. This is part of how the CHRNG gene supports nerve to muscle signaling before birth and early muscle development.
The CHRNG gene provides one part of a muscle surface receptor that detects acetylcholine, a nerve signal chemical. When a motor nerve releases this chemical, the receptor starts the muscle cell response.
After acetylcholine binds, the receptor briefly opens a channel in the muscle cell surface. This allows charged particles to move in and helps the muscle fiber switch on for movement.
During fetal development, this receptor helps shape the neuromuscular junction (the contact point between a nerve and a muscle). Later, as muscles mature, the gamma based form is largely replaced by a version used after birth.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some instances, though, a variant can change a gene’s function more significantly and may contribute to or lead to a genetic condition.
Genetic variants
What if the gene does not work
CHRNG gene variants can alter the fetal nerve to muscle receptor by making the gamma subunit too short, unstable, or less able to join the channel, so signaling for movement during development is reduced. In plain terms, how CHRNG gene variants affect fetal muscle signaling depends on the specific change. Milder variants may leave some channel activity, while more disruptive variants can nearly abolish it. This often influences how early reduced fetal movement begins and how marked features of multiple pterygium syndrome are.
How variants are linked to conditions
Pathogenic variants in the CHRNG gene are linked to rare inherited conditions called multiple pterygium syndromes. In established CHRNG gene variants and related conditions, the main diagnoses are Escobar syndrome, also called nonlethal multiple pterygium syndrome, and a more severe lethal form of multiple pterygium syndrome. These conditions can include reduced movement before birth, joint contractures, and skin webbing, with severity varying between affected people and families.
A variant is not necessarily a diagnosis
Variants in genes are a usual part of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant tied to a condition suggests a possible association rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well understood variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For CHRNG, risk is mainly shaped by inheritance rather than lifestyle. A child is most likely to be affected when both parents carry a changed CHRNG gene, so family history and parents being blood relatives can raise the chance. There is not enough evidence to say that diet, exercise, or other daily habits change this risk.
Inheritance of CHRNG variants
For families asking how CHRNG gene variants are inherited, the well-established pattern is autosomal recessive. This means a child usually inherits one CHRNG gene variant from each parent, and the parents are often healthy carriers. When both parents carry a variant in the CHRNG gene, each pregnancy has a 25% chance of being affected, a 50% chance of resulting in a carrier child, and a 25% chance of resulting in a child without the familial variant. Because the CHRNG gene is on chromosome 2, this inheritance pattern is the same for girls and boys.
What does my CHRNG result mean for my family?
For CHRNG-related conditions, family members are often affected through a recessive pattern, which usually means both parents are healthy carriers. Brothers and sisters may also be affected or may be carriers, so the result can matter for siblings and future pregnancies. More distant relatives may also carry the same gene change, especially on the parent’s side where it was inherited.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the CHRNG gene, a lab can do genetic testing for CHRNG variants using blood, saliva, or a cheek swab. The lab reads the gene's DNA code and looks for variants that may help explain findings before birth or at birth, often as part of a panel or exome test.
When should I consider getting a genetic test?
Testing for CHRNG may be worth considering when a pregnancy or child has signs of reduced movement before birth, joint stiffness or fixed joints, and skin webbing between joints, which can fit multiple pterygium syndrome. It can also help when this condition runs in the family or when parents want carrier testing after a pregnancy or child with it.
A genetic result is only one part of your health story
Genetic test results can offer useful insight, but how much they show depends on the condition and the type of variant involved. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when considered alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas such as medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same medication works well for one person, seems weaker for another, or causes more side effects in someone else. Small differences in genes can change how the body breaks down a drug, moves it through the body, or responds to it at its target, and this kind of variation is common.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes can affect a person’s response to medications. It examines links between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can support more informed, more individualized treatment decisions. You can learn more about this topic in the LearnHub.
Drugs influenced by the CHRNG gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so any questions about medicines, side effects, or new symptoms are best discussed with your doctor.
History
Throughout history, clinicians described babies born with joint stiffness and webbing of the skin, features now recognized in some people with CHRNG-related conditions. Initially understood only through visible traits, later recognized as tied to a specific gene, these findings were linked to forms of multiple pterygium syndrome, including Escobar syndrome. From these first observations, research expanded steadily. In the late 20th century and early 2000s, genetic studies connected some of these inherited patterns to variants in the CHRNG gene. That work also helped clarify why signs often begin before birth, during a stage when this gene is active in developing muscle. Over time, descriptions became more precise as doctors could confirm the diagnosis with genetic testing.